annual CFO:
-$144.03M+$249.24M(+63.38%)Summary
- As of today (June 28, 2025), LEGN annual cash flow from operations is -$144.03 million, with the most recent change of +$249.24 million (+63.38%) on December 31, 2024.
- During the last 3 years, LEGN annual CFO has risen by +$54.43 million (+27.43%).
- LEGN annual CFO is now -146.81% below its all-time high of $307.68 million, reached on December 31, 2018.
Performance
LEGN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$103.75M-$21.68M(-26.41%)Summary
- As of today (June 28, 2025), LEGN quarterly cash flow from operations is -$103.75 million, with the most recent change of -$21.68 million (-26.41%) on March 31, 2025.
- Over the past year, LEGN quarterly CFO has dropped by -$119.27 million (-768.60%).
- LEGN quarterly CFO is now -620.15% below its all-time high of $19.95 million, reached on September 30, 2019.
Performance
LEGN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$263.31M-$119.27M(-82.81%)Summary
- As of today (June 28, 2025), LEGN TTM cash flow from operations is -$263.31 million, with the most recent change of -$119.27 million (-82.81%) on March 31, 2025.
- Over the past year, LEGN TTM CFO has dropped by -$24.76 million (-10.38%).
- LEGN TTM CFO is now -6082.32% below its all-time high of -$4.26 million, reached on March 31, 2019.
Performance
LEGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LEGN Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +63.4% | -768.6% | -10.4% |
3 y3 years | +27.4% | -31.9% | -5.2% |
5 y5 years | -73.4% | -126.6% | -111.3% |
LEGN Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +63.4% | -768.6% | +25.5% | -84.6% | +33.0% |
5 y | 5-year | -73.4% | +63.4% | -768.6% | +25.5% | -111.3% | +33.0% |
alltime | all time | -146.8% | +63.4% | -620.1% | +25.5% | -6082.3% | +33.0% |
LEGN Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$103.75M(+26.4%) | -$263.31M(+82.8%) |
Dec 2024 | -$144.03M(-63.4%) | -$82.08M(+8.3%) | -$144.03M(-8.6%) |
Sep 2024 | - | -$75.82M(+4492.5%) | -$157.60M(+10.5%) |
Jun 2024 | - | -$1.65M(-110.6%) | -$142.63M(-40.2%) |
Mar 2024 | - | $15.52M(-116.2%) | -$238.54M(-39.3%) |
Dec 2023 | -$393.28M(+95.4%) | -$95.64M(+57.2%) | -$393.28M(+13.2%) |
Sep 2023 | - | -$60.85M(-37.6%) | -$347.37M(-3.1%) |
Jun 2023 | - | -$97.57M(-29.9%) | -$358.64M(+37.0%) |
Mar 2023 | - | -$139.22M(+179.9%) | -$261.81M(+30.1%) |
Dec 2022 | -$201.28M(+1.4%) | -$49.74M(-31.0%) | -$201.28M(-9.0%) |
Sep 2022 | - | -$72.11M(+9644.9%) | -$221.09M(+14.2%) |
Jun 2022 | - | -$740.00K(-99.1%) | -$193.57M(-22.7%) |
Mar 2022 | - | -$78.69M(+13.1%) | -$250.37M(+26.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$198.47M(-11.0%) | -$69.55M(+56.0%) | -$198.47M(+7.4%) |
Sep 2021 | - | -$44.59M(-22.5%) | -$184.87M(-9.7%) |
Jun 2021 | - | -$57.54M(+114.8%) | -$204.65M(+0.3%) |
Mar 2021 | - | -$26.79M(-52.1%) | -$204.00M(-8.5%) |
Dec 2020 | -$223.00M(+168.5%) | -$55.95M(-13.1%) | -$223.00M(-1.8%) |
Sep 2020 | - | -$64.37M(+13.2%) | -$227.04M(+59.1%) |
Jun 2020 | - | -$56.88M(+24.2%) | -$142.72M(+14.5%) |
Mar 2020 | - | -$45.80M(-23.7%) | -$124.60M(+50.0%) |
Dec 2019 | -$83.06M(-127.0%) | -$59.99M(-400.7%) | -$83.06M(+259.9%) |
Sep 2019 | - | $19.95M(-151.5%) | -$23.08M(-46.4%) |
Jun 2019 | - | -$38.77M(+810.2%) | -$43.02M(+910.2%) |
Mar 2019 | - | -$4.26M | -$4.26M |
Dec 2018 | $307.68M | - | - |
FAQ
- What is Legend Biotech annual cash flow from operations?
- What is the all time high annual CFO for Legend Biotech?
- What is Legend Biotech annual CFO year-on-year change?
- What is Legend Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for Legend Biotech?
- What is Legend Biotech quarterly CFO year-on-year change?
- What is Legend Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for Legend Biotech?
- What is Legend Biotech TTM CFO year-on-year change?
What is Legend Biotech annual cash flow from operations?
The current annual CFO of LEGN is -$144.03M
What is the all time high annual CFO for Legend Biotech?
Legend Biotech all-time high annual cash flow from operations is $307.68M
What is Legend Biotech annual CFO year-on-year change?
Over the past year, LEGN annual cash flow from operations has changed by +$249.24M (+63.38%)
What is Legend Biotech quarterly cash flow from operations?
The current quarterly CFO of LEGN is -$103.75M
What is the all time high quarterly CFO for Legend Biotech?
Legend Biotech all-time high quarterly cash flow from operations is $19.95M
What is Legend Biotech quarterly CFO year-on-year change?
Over the past year, LEGN quarterly cash flow from operations has changed by -$119.27M (-768.60%)
What is Legend Biotech TTM cash flow from operations?
The current TTM CFO of LEGN is -$263.31M
What is the all time high TTM CFO for Legend Biotech?
Legend Biotech all-time high TTM cash flow from operations is -$4.26M
What is Legend Biotech TTM CFO year-on-year change?
Over the past year, LEGN TTM cash flow from operations has changed by -$24.76M (-10.38%)